Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model-Reference-Cited by-同舟云学术

Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model

Published:2003-12 Issue:4 Volume:6 Page:272-280
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Bok R A,Hansell E J,Nguyen T P,Greenberg N M,McKerrow J H,Shuman M A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/4500676.pdf

Reference22 articles.

1. Kim SJ et al. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis. Clin Cancer Res 1998; 4: 177–182.

2. Powell WC et al. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res 1993; 53: 417–422.

3. Shalinsky DR et al. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann NY Acad Sci 1999; 878: 236–270.

4. Van Veldhuizen PJ, Sadasivan R, Cherian R, Wyatt A . Urokinase-type plasminogen activator expression in human prostate carcinomas. Am J Med Sci 1996; 312: 8–11.

5. Bubley GJ et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol 1999; 17: 3461–3467.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunomodulatory Role of Surfactant Protein-D in a Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) Model;Frontiers in Immunology;2022-07-07

2. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review;International Journal of Molecular Sciences;2021-03-30

3. Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity;Journal of Clinical Investigation;2018-12-10

4. Exploring the oncoproteomic response of human prostate cancer to therapeutic radiation using data-independent acquisition (DIA) mass spectrometry;The Prostate;2018-03-09

5. SPINT2 Deregulation in Prostate Carcinoma;Journal of Histochemistry & Cytochemistry;2015-10-06